Vanda Pharmaceuticals Inc (LTS:0LKB)
$ 5.91 -0.14 (-2.23%) Market Cap: 357.20 Mil Enterprise Value: 167.97 Mil PE Ratio: 0 PB Ratio: 1.24 GF Score: 71/100

Q1 2026 Vanda Pharmaceuticals Inc Earnings Call Transcript

May 06, 2026 / 08:30PM GMT
Release Date Price: $7.48 (+0.81%)
Operator

Thank you for standing by. My name is Jordan, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Q1 2026 Vanda Pharmaceuticals Inc's earnings conference call. (Operator Instructions)

I would now like to turn the call over to Vanda's Chief Financial Officer, Kevin Moran. Please go ahead.

Kevin Moran
Vanda Pharmaceuticals Inc - Chief Financial Officer, Senior Vice President, Treasurer

Thank you, Jordan. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceuticals' first-quarter 2026 performance. Our first-quarter 2026 results were released this afternoon and are available on the SECâs EDGAR system and on our website, www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website.

Joining me on todayâs call is Dr. Mihael Polymeropoulos, our President, Chief Executive Officer, and Chairman of the Board. Following my introductory remarks, Mihael will update you on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot